ChromaDex’s (CDXC -0.2%) key ingredient, Tru Niagen®, is available in Nestlé Health Science’s new Celltrient™ Cellular Energy.

It is a protein-based flavored drink mix to help renew natural processes that decline as we age.

Celltrient Energy is the first product launched from ChromaDex and Nestlé Health Science partnership entered to supply Tru Niagen within the medical nutrition and consumer health categories in December 2018.

 “Tru Niagen, the only proprietary form of NR, provides healthy aging and energy support at the cellular level by safely and effectively increasing NAD+ levels.” says ChromaDex CEO Rob Fried.

Press Release


Source link

Comments to: ChromaDex and Nestle launches their first Tru Niagen drink (NASDAQ:CDXC)

Your email address will not be published. Required fields are marked *

Attach images - Only PNG, JPG, JPEG and GIF are supported.


Welcome to Typer

Brief and amiable onboarding is the first thing a new user sees in the theme.
Join Typer
Registration is closed.